C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2011
11/17/2011	WO2011141705A1 Novel cationic lipids and methods of use thereof
11/17/2011	US20110281923 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
11/17/2011	CA2799091A1 Novel cationic lipids and methods of use thereof
11/16/2011	EP2386539A2 Modified lysine-mimetic compounds
11/16/2011	EP2225243B1 Derivatives of N-heterocyclic-6-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
11/16/2011	EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/16/2011	CN102241679A Process for the synthesis of 4h-imidazo [1,5-a] [1,4] benzodiazepines, in particular midazolam and salts thereof
11/16/2011	CN102241678A Antitumor effect and application of alicyclic structure-containing compound
11/16/2011	CN102241643A 1-heterocycle-5-substituted phenyl-1-pentanone compound and preparation method and application thereof
11/16/2011	CN102241634A Preparation method of 2-nitro-4,5-dicyan-1H-imidazole
11/16/2011	CN102241633A Linolenic acid-carnosine composite and preparation method thereof
11/16/2011	CN102241632A Preparation method of ozagrel bulk drug
11/16/2011	CN101412697B 1-amino hydantoin derivative hapten, antigen and antibody and uses thereof
11/15/2011	CA2549995C Ketone compounds and compositions for cholesterol management and related uses
11/15/2011	CA2435067C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
11/10/2011	WO2011140232A2 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
11/10/2011	WO2011139708A2 Improved hydrogen release from complex metal hydrides by solvation in ionic liquids
11/10/2011	WO2011138409A1 Combretastatin analogs for use in the treatment of cancer
11/10/2011	WO2011088075A3 Novel salts, polymorphs, and synthetic processes regarding imidazole derivative
11/10/2011	US20110275830 Method for preparation of 2,4-dinitroimidazole which is an intermediate for insensitive meltcastable molecular explosive
11/10/2011	US20110275829 Androgen receptor modulating compounds, preparation and uses thereof
11/10/2011	US20110275823 Phenylimidazole compounds
11/10/2011	US20110275813 Bicylic 1,3-diones and Their Use as Insecticides, Acaricides and/or Fungicides
11/10/2011	US20110275799 PROCESS FOR THE SYNTHESIS OF 4H-IMIDAZO [1,5-a] [1,4] BENZODIAZEPINES, IN PARTICULAR MIDAZOLAM AND SALTS THEREOF
11/10/2011	US20110275797 N-acyl anthranilic acid derivative or salt thereof
11/10/2011	US20110275685 Salt and polymorphs of a kinesin inhibitor compound
11/10/2011	US20110275636 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
11/10/2011	US20110275567 Aqueous composition containing follicle-stimulating hormone
11/10/2011	US20110275070 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
11/10/2011	US20110274907 Curative fibre components
11/10/2011	CA2798082A1 Desazadesferrothiocin analogues as metal chelation agents
11/09/2011	EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011	EP2090570B1 Imidazole derivative
11/09/2011	EP1658263B9 Novel aminobenzophenone compounds
11/09/2011	EP1370539B1 Hiv inhibiting n-aminoimidazole derivatives
11/09/2011	CN101747280B Method for preparing detomidine and the intermediate thereof
11/09/2011	CN101455199B Naphthenic acid imidazoline and preparation method thereof
11/08/2011	US8053439 Benzophenone derivatives useful for inhibiting formation of microtubule
11/08/2011	US8053435 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same
11/08/2011	CA2452205C Activators for oligonucleotide synthesis
11/08/2011	CA2343414C Fc receptor modulators and uses thereof
11/03/2011	US20110269968 Non-Signal Imidazole Reagents for Mass Spectrometry Analysis of Phosphomonoesters
11/03/2011	US20110269965 Ring Closing and Related Methods and Intermediates
11/03/2011	US20110269803 Azole compounds used as tuberculostatic and leishmanicide agents
11/03/2011	US20110269769 Imidazole derivatives useful as inhibitors of faah
11/02/2011	EP2383814A1 Organic electroluminescent device
11/02/2011	EP2238115B1 Novel imidazolinylmethyl aryl sulfonamides
11/02/2011	EP1732901B1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
11/02/2011	CN102232065A Photobase generator
11/02/2011	CN102229567A Method for purifying 1-alkyl-3-methylimidazole tetrafluoro borate ionic liquid
11/02/2011	CN102229566A Structure of drug for treating neurodegenerative disease
11/02/2011	CN101402608B Method for producing bactericide prochloraz
11/01/2011	USRE42889 α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/01/2011	US8048911 Melanin eliminator preparation
11/01/2011	CA2531911C Specific glucocorticosteroid having an anti-inflammatory activity
11/01/2011	CA2481261C Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
11/01/2011	CA2476586C Sulfonyl-derivatives as novel inhibitors of histone deacetylase
11/01/2011	CA2473839C Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
11/01/2011	CA2409741C Tnf-.alpha. production inhibitors
10/2011
10/27/2011	WO2011132712A1 Novel hydroxamic acid derivative
10/27/2011	WO2011132048A1 Heteroaryl compounds as pde10a inhibitors
10/27/2011	US20110263868 Novel crystals and process of making 5-(-methyl)-2-methoxy-benzoic acid
10/27/2011	US20110263664 Inhibitors of PIM-1 Protein Kinases, Compositions and Methods for Treating Prostate Cancer
10/27/2011	US20110263626 Novel bradykinin b1-antagonists
10/27/2011	US20110263543 Anti inflammatory compounds
10/27/2011	US20110263539 Ship 1 modulator compounds
10/27/2011	US20110263486 Inhibitors of Cancer Cell, T-Cell and Keratinocyte Proliferation
10/27/2011	US20110262626 Antibody Protective Agent And Methods Of Using Same
10/27/2011	US20110262510 Process For Producing N-Halogenated Hydantoins
10/26/2011	EP2380898A1 Process to make glucocortisoid compounds
10/26/2011	EP2380882A1 Salts of heterocyclic anions and their uses as ionic conductive materials
10/26/2011	EP2380880A2 Method for producing concentrated solutions of metal salts in ionic liquids
10/26/2011	EP1259481B1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same
10/25/2011	US8044215 Methods for the preparation of amphillic nitrogen containing imidazolinium derivative compounds
10/25/2011	US8044090 N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
10/25/2011	US8044082 N-phenylacetamide inhibitors of the enzyme SOAT-1 and pharmaceutical/cosmetic compositions comprised thereof
10/25/2011	US8044053 Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators
10/25/2011	US8044048 Derivatives of sulindac, use thereof and preparation thereof
10/25/2011	CA2379974C Preparation of compounds useful for the detection of hypoxia
10/20/2011	WO2011071881A3 Microwave-assisted synthesis of n-heterocyclic carbene transition metal complexes
10/20/2011	WO2011063261A3 Pathogen protection garment with both rapid and persistent rechargable self-sterilization
10/20/2011	US20110257196 Compounds for treatment of cancer
10/20/2011	US20110257163 Gamma secretase modulators
10/20/2011	US20110256561 Liver disease marker, method and apparatus for measuring the same, and method for assaying pharmaceutical preparation
10/20/2011	US20110256067 Contrast agents endowed with high relaxivity
10/19/2011	EP2376431A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-hiv agents
10/19/2011	EP2225245B1 N-phenyl-imidazo(1,2-a)pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
10/19/2011	EP1482931B1 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/19/2011	CN1993357B Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
10/19/2011	CN102224452A Diamine, polyimide, liquid crystal aligning agent, and liquid crystal alignment film
10/19/2011	CN102224217A Electroluminescent device using the electroluminescent compounds
10/19/2011	CN102219776A Cyanoacetate derivative containing imidazolidine groups as well as preparation method and application thereof
10/19/2011	CN102219772A Cortex pseudolaricis acid complex with bioactivity and preparation method thereof
10/19/2011	CN102219743A Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
10/19/2011	CN102219742A Method for synthesizing 1,3-dibenzyl imidazoline-2-keto-cis-4,5-dicarboxylic acid
10/19/2011	CN101091488B Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same
10/18/2011	US8039501 Synephrine derivatives useful as anti-inflammatory agents
10/18/2011	US8039499 Ester compound and its use
10/18/2011	US8039498 Imidazole compounds
10/13/2011	WO2011086412A3 Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof

1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 345